Data / Form D filings / GeneTex International Corp
GeneTex International Corp: Form D filing
GeneTex International Corp, a biotechnology company in Hsninchu City, Taiwan, Province Of China, filed a Form D with the SEC in 2012. The latest, on March 15, 2012, reports $4.3 million sold of a $4.3 million offering to 43 investors.
Find out what GeneTex International Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6F-2, NO. 89, DONGMEI RD., EAST DISTRICT, Hsninchu City, Taiwan, Province Of China, 300
- Phone
- 886-3-620-8988
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Taiwan, Province Of China
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1544801
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2012 | New notice | $4,300,000 | $4,300,000 | $0 | 43 | Mar 1, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul Chen | Director | |
| Wen-Kuang Hsu | Executive Officer, Director | |
| K.Y. Peng | Executive Officer | |
| Horace H. Loh | Director | |
| Teresa Yang-Feng | Director |
Every Form D from the week of Mar 12, 2012 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GeneTex International Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.